Skip to content

Texas legislature approves financial support for scientific investigations into ibogaine's potential for treating opioid addictions and associated mental health issues.

In foreign regions, the illegally categorized psychoactive substance, Ibogaine, is employed for addressing addiction issues, post-traumatic stress disorder (PTSD), emotional struggles (depression), and trauma-induced brain injuries.

Illicit psychoactive substance Ibogaine, outlawed in the USA, finds application overseas for...
Illicit psychoactive substance Ibogaine, outlawed in the USA, finds application overseas for addressing addiction issues, PTSD, melancholy, and brain injuries resulting from trauma.

Texas legislature approves financial support for scientific investigations into ibogaine's potential for treating opioid addictions and associated mental health issues.

Free Yourself from Opioid Hell with Texas's New Bill!

Escape the grasp of opioid addiction with the help of a groundbreaking new treatment making its way to the Lone Star State. Welcome to the revolution, Texas, it's time to bring TPR Now*, Texas Public Radio's newsletter that delivers the hottest updates right to your inbox every morning.

Waving goodbye to a staggering death toll, the Texas House of Representatives has unanimously agreed to create a grant program funding a public-private partnership. This cooperation aims to push ibogaine, a powerful psychoactive substance, through FDA-approved clinical trials for opioid use disorders and other neurological and mental health challenges for which ibogaine has shown effectiveness. House Bill 3717 passed its final vote in the House with an overwhelming bipartisan consensus.

For almost two decades, nearly 727,000 Americans have succumbed to opioid overdose deaths. With many US citizens trying traditional treatments to no avail, they've moved abroad to cure their addictions with ibogaine, a substance legal and unregulated in countries like Mexico.

State Representative Cody Harris (R-Palestine), sponsor of the bill, acknowledged the need to provide effective treatment solutions available in the USA and believes ibogaine could meet that need. Harris referenced a recent observational study led by Stanford University with thirty Special Operations Veterans undergoing ibogaine therapy in Mexico. This study demonstrated remarkable reductions in symptoms related to Traumatic Brain Injury, PTSD, depression, and anxiety.

"We're not merely playing catch-up here; ibogaine therapies are already flourishing just beyond our borders," Harris stated. "Texas can be the voice of change, leading the charge in bringing this life-transforming treatment back home."

Ibogaine is a compound derived from the African iboga shrub, traditionally used in healing rituals for centuries. Although researchers are still unsure of exactly how it impacts the brain, they suspect it may encourage new neural connections to promote long-term effects. However, due to potential cardiac risks, a medically trained team must administer ibogaine.

Numerous US combat veterans testified in favor of the bill, including Dakota Meyer, a Marine Corps veteran and Congressional Medal of Honor recipient.

"I couldn't kick alcohol addiction," said Meyer. "Ibogaine isn't a temporary fix for symptoms. It heals. It vanquishes addiction. I've gone years without an anxiety attack since. This treatment saved my life."

Last month, the Senate passed its counterpart bill, Senate Bill 2308. If the Senate adopts the revised House version, the bill will head to Governor Greg Abbott's desk for his signature.

Enrichment Notes:

  • House Bill 3717 (HB 3717) is legislation that seeks to initiate grant programs for FDA-approved clinical trials of ibogaine, a therapeutic compound with potential for treating opioid use disorders and other neurological or mental health problems.
  • HB 3717 stipulates that the Texas Health and Human Services Commission (HHSC) shall establish and administer grants for eligible public or private organizations that can conduct such clinical trials, provided they submit detailed safety protocols, patient aftercare plans, intellectual property proposals, financial assurances, and matching funds.
  • Advocates of the bill believe ibogaine presents an innovative treatment option, currently under-exploited due to regulatory barriers in the US. The passage of the bill would bring this treatment method closer to home for many struggling with addiction and other health issues.
  1. Delve deeper into groundbreaking developments within health-and-wellness, as Texas moves forward with House Bill 3717, aiming to fund ibogaine clinical trials for mental health challenges like opioid addiction, PTSD, depression, and anxiety.
  2. Stay informed with TPR Now, Texas Public Radio's newsletter, and catch updates on the advancements in science, as ibogaine, a potential life-changing therapy, advances through FDA-approved clinical trials thanks to the new bill.
  3. Elevate your knowledge about mental health, nutrition, and therapies-and-treatments as Texas becomes the hub for research on ibogaine, a promising substance proven effective in combating opioid addiction and other neurological disorders.

Read also:

    Latest